Single-cell transcriptomics reveals MAFB-driven macrophage reprogramming and immune divergence in recurrent

Yijing He1,2, Jiaming Yu3, Meng Huang4

  • 1Center for Stem Cell Biology and Tissue Engineering, Key Laboratory of Stem Cells and Tissue Engineering, Ministry of Education, Sun Yat-sen University, Guangzhou, 510080, China.

BMC Cancer
|June 29, 2026
PubMed
Summary

Recurrent glioblastoma (GBM) features a distinct CXCL3⁺ tumor-associated macrophage (TAM) population regulated by MAFB. Targeting this MAFB-driven macrophage program may offer new therapeutic strategies for aggressive brain tumors.

Related Concept Videos